Aspire Biopharma Files 8-K, Formerly PowerUp Acquisition Corp.

Ticker: ASBPW · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1847345

Sentiment: neutral

Topics: corporate-event, name-change, financial-statements

Related Tickers: ASBP

TL;DR

Aspire Biopharma (fka PowerUp Acquisition) filed an 8-K on June 18th for events on June 17th, including financials.

AI Summary

Aspire Biopharma Holdings, Inc. filed an 8-K on June 18, 2025, reporting on events that occurred on June 17, 2025. The filing primarily concerns "Other Events" and includes "Financial Statements and Exhibits." The company was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp. before changing its name on February 22, 2021.

Why It Matters

This 8-K filing indicates ongoing corporate activities and potential changes for Aspire Biopharma Holdings, Inc., including the formalization of financial statements and exhibits.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting on corporate events and financial statements, not indicating any immediate financial distress or significant new risks.

Key Players & Entities

FAQ

What specific "Other Events" are being reported by Aspire Biopharma Holdings, Inc. in this 8-K?

The filing indicates "Other Events" as an item, but the specific details of these events are not elaborated in the provided text excerpt.

When did Aspire Biopharma Holdings, Inc. officially change its name from PowerUp Acquisition Corp.?

The company's name was changed from PowerUp Acquisition Corp. (and PowsedrUp Acquisition Corp.) on February 22, 2021.

What is the SIC code for Aspire Biopharma Holdings, Inc.?

The Standard Industrial Classification (SIC) code for Aspire Biopharma Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

What is the state of incorporation for Aspire Biopharma Holdings, Inc.?

Aspire Biopharma Holdings, Inc. is incorporated in Delaware.

What is the business address of Aspire Biopharma Holdings, Inc.?

The business address is 23150 Fashion Drive, Suite 232, Estero, FL 33928.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Aspire Biopharma Holdings, Inc. (ASBPW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing